SMAP200600037A - Uree trisostituite come inibitori di citochina - Google Patents

Uree trisostituite come inibitori di citochina

Info

Publication number
SMAP200600037A
SMAP200600037A SM200600037T SM200600037T SMAP200600037A SM AP200600037 A SMAP200600037 A SM AP200600037A SM 200600037 T SM200600037 T SM 200600037T SM 200600037 T SM200600037 T SM 200600037T SM AP200600037 A SMAP200600037 A SM AP200600037A
Authority
SM
San Marino
Prior art keywords
cytokine inhibitors
trisubstituted urea
trisubstituted
urea
cytokine
Prior art date
Application number
SM200600037T
Other languages
English (en)
Other versions
SMP200600037B (it
Inventor
Todd Andrew Brugel
Jennifer Anne Townes
Michael Philip Clark
Mark Sabat
Adam Golebiowski
Biswanath De
Stephen Matthew Berberich
Gregory Kent Bosch
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SMP200600037B publication Critical patent/SMP200600037B/it
Publication of SMAP200600037A publication Critical patent/SMAP200600037A/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SM200600037T 2004-04-22 2005-04-20 Uree trisostituite come inibitori di citochina SMAP200600037A (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56474504P 2004-04-22 2004-04-22
PCT/US2005/013869 WO2005105758A1 (en) 2004-04-22 2005-04-20 Tri-substituted ureas as cytokine inhibitors

Publications (2)

Publication Number Publication Date
SMP200600037B SMP200600037B (it) 2006-11-22
SMAP200600037A true SMAP200600037A (it) 2006-11-22

Family

ID=34967029

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200600037T SMAP200600037A (it) 2004-04-22 2005-04-20 Uree trisostituite come inibitori di citochina

Country Status (27)

Country Link
US (2) US7402589B2 (it)
EP (2) EP1737830A1 (it)
JP (2) JP2007534688A (it)
KR (1) KR100883937B1 (it)
CN (2) CN1946701A (it)
AR (2) AR050411A1 (it)
AT (1) ATE402927T1 (it)
AU (1) AU2005238484A1 (it)
BR (1) BRPI0510128A (it)
CA (2) CA2564589A1 (it)
DE (1) DE602005008581D1 (it)
DK (1) DK1747204T3 (it)
ES (1) ES2311223T3 (it)
HR (1) HRP20080489T3 (it)
IL (1) IL178459A0 (it)
MA (1) MA28638B1 (it)
MX (2) MXPA06012188A (it)
NO (1) NO20065142L (it)
PE (2) PE20060338A1 (it)
PL (1) PL1747204T3 (it)
PT (1) PT1747204E (it)
RU (1) RU2338739C2 (it)
SI (1) SI1747204T1 (it)
SM (1) SMAP200600037A (it)
TW (2) TW200538105A (it)
WO (2) WO2005105757A1 (it)
ZA (1) ZA200609326B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
CN108976172B (zh) * 2017-05-31 2021-12-07 华东师范大学 一类4-嘧啶二胺类小分子有机化合物及其衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
JP2001521934A (ja) * 1997-11-03 2001-11-13 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症薬としての芳香族ヘテロ環式化合物
DE60023853T2 (de) * 1999-03-12 2006-05-24 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
EP1395561A1 (en) * 2001-05-25 2004-03-10 Boehringer Ingelheim Pharmaceuticals Inc. Carbamate and oxamide compounds as inhibitors of cytokine production
CA2453147A1 (en) * 2001-07-11 2003-01-23 Boehringer Ingelheim Pharmaceuticals, Inc. Methods of treating cytokine mediated diseases

Also Published As

Publication number Publication date
SMP200600037B (it) 2006-11-22
MXPA06012189A (es) 2007-01-17
TW200539883A (en) 2005-12-16
CN1946700A (zh) 2007-04-11
AR048874A1 (es) 2006-06-07
US7402589B2 (en) 2008-07-22
US7449474B2 (en) 2008-11-11
JP2007534688A (ja) 2007-11-29
PE20060338A1 (es) 2006-05-09
KR100883937B1 (ko) 2009-02-18
BRPI0510128A (pt) 2007-10-02
CA2564589A1 (en) 2005-11-10
US20050245555A1 (en) 2005-11-03
ATE402927T1 (de) 2008-08-15
ES2311223T3 (es) 2009-02-01
NO20065142L (no) 2006-11-08
MA28638B1 (fr) 2007-06-01
US20050239811A1 (en) 2005-10-27
AR050411A1 (es) 2006-10-25
KR20060133110A (ko) 2006-12-22
RU2338739C2 (ru) 2008-11-20
EP1747204A1 (en) 2007-01-31
DK1747204T3 (da) 2008-11-10
MXPA06012188A (es) 2007-01-17
AU2005238484A1 (en) 2005-11-10
EP1747204B1 (en) 2008-07-30
CA2564587A1 (en) 2005-11-10
JP2007534689A (ja) 2007-11-29
HRP20080489T3 (en) 2008-11-30
WO2005105758A1 (en) 2005-11-10
PE20060258A1 (es) 2006-04-24
ZA200609326B (en) 2007-12-27
SI1747204T1 (sl) 2008-12-31
IL178459A0 (en) 2007-02-11
RU2006140694A (ru) 2008-06-20
PL1747204T3 (pl) 2009-01-30
WO2005105757A1 (en) 2005-11-10
DE602005008581D1 (en) 2008-09-11
CN1946701A (zh) 2007-04-11
EP1737830A1 (en) 2007-01-03
TW200538105A (en) 2005-12-01
PT1747204E (pt) 2008-10-29

Similar Documents

Publication Publication Date Title
NO20076678L (no) Glutamataggrekanaseinhibitorer
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
CY2014013I1 (el) Αναστολεις διπεπτιδυλ πεπτιδασης
DK1745052T3 (da) HIV-intergrase-inhibitorer: cykliske pyrimidinonforbindelser
ATE461200T1 (de) Inhibitoren von cysteinprotease
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
DK1934236T3 (da) Heterobifunktionelle pan-selektininhibitorer
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DK2253614T3 (da) IAP-inhibitorer
DK1778718T3 (da) Iap-inhibitorer
DK1704145T3 (da) Selektive kinaseinhibitorer
AT500849B8 (de) Harnstoffdosiervorrichtung
ATE545642T1 (de) Mmp-inhibitoren
DK1713805T3 (da) Kinaseinhibitorer
ATE418545T1 (de) Nnrt-inhibitoren
ATE429417T1 (de) Hiv-protease-inhibitoren
DE602005012550D1 (de) Inhibitoren des glycintransports
NO20044269L (no) Smamolekylaere inntrengningsinhibitorer
DK1799707T3 (da) Rekombineret Kunitztypeinhibitor
ITMI20051244A1 (it) Dispositivo di trasporto
NO20045464D0 (no) Palleteringssystem
SMAP200600037A (it) Uree trisostituite come inibitori di citochina
ITMI20041626A1 (it) Inibitori della chinurenina-ammino-trasferasi
SE0500443L (sv) Explosionshämmare
ITVR20040067A1 (it) Dispositivo di refrigerazione